Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec;23(1):1-18.
doi: 10.1093/humupd/dmw039. Epub 2016 Oct 26.

Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors

Affiliations
Review

Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors

Hsun-Ming Chang et al. Hum Reprod Update. 2016 Dec.

Abstract

Background: Initially identified for their capability to induce heterotopic bone formation, bone morphogenetic proteins (BMPs) are multifunctional growth factors that belong to the transforming growth factor β superfamily. Using cellular and molecular genetic approaches, recent studies have implicated intra-ovarian BMPs as potent regulators of ovarian follicular function. The bi-directional communication of oocytes and the surrounding somatic cells is mandatory for normal follicle development and oocyte maturation. This review summarizes the current knowledge on the physiological role and molecular determinants of these ovarian regulatory factors within the human germline-somatic regulatory loop.

Objective and rationale: The regulation of ovarian function remains poorly characterized in humans because, while the fundamental process of follicular development and oocyte maturation is highly similar across species, most information on the regulation of ovarian function is obtained from studies using rodent models. Thus, this review focuses on the studies that used human biological materials to gain knowledge about human ovarian biology and disorders and to develop strategies for preventing, diagnosing and treating these abnormalities.

Search methods: Relevant English-language publications describing the roles of BMPs or growth differentiation factors (GDFs) in human ovarian biology and phenotypes were comprehensively searched using PubMed and the Google Scholar database. The publications included those published since the initial identification of BMPs in the mammalian ovary in 1999 through July 2016.

Outcomes: Studies using human biological materials have revealed the expression of BMPs, GDFs and their putative receptors as well as their molecular signaling in the fundamental cells (oocyte, cumulus/granulosa cells (GCs) and theca/stroma cells) of the ovarian follicles throughout follicle development. With the availability of recombinant human BMPs/GDFs and the development of immortalized human cell lines, functional studies have demonstrated the physiological role of intra-ovarian BMPs/GDFs in all aspects of ovarian functions, from follicle development to steroidogenesis, cell-cell communication, oocyte maturation, ovulation and luteal function. Furthermore, there is crosstalk between these potent ovarian regulators and the endocrine signaling system. Dysregulation or naturally occurring mutations within the BMP system may lead to several female reproductive diseases. The latest development of recombinant BMPs, synthetic BMP inhibitors, gene therapy and tools for BMP-ligand sequestration has made the BMP pathway a potential therapeutic target in certain human fertility disorders; however, further clinical trials are needed. Recent studies have indicated that GDF8 is an intra-ovarian factor that may play a novel role in regulating ovarian functions in the human ovary.

Wider implications: Intra-ovarian BMPs/GDFs are critical regulators of folliculogenesis and human ovarian functions. Any dysregulation or variations in these ligands or their receptors may affect the related intracellular signaling and influence ovarian functions, which accounts for several reproductive pathologies and infertility. Understanding the normal and pathological roles of intra-ovarian BMPs/GDFs, especially as related to GC functions and follicular fluid levels, will inform innovative approaches to fertility regulation and improve the diagnosis and treatment of ovarian disorders.

Keywords: activin receptor like-kinase; bone morphogenetic proteins; female infertility; growth differentiation factors; human granulosa cell line; human granulosa cells; human ovary.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Phylogenetic relationship of the BMP/GDF subfamily members. The alignment of 21 BMP/GDF-related ligands was based on published literature: (Ducy and Karsenty, 2000; Mazerbourg and Hsueh, 2006; Rider and Mulloy, 2010). Ligands with an asterisk are expressed in the human ovary. BMP/GDF, bone morphogenetic protein/growth differentiation factor.
Figure 2
Figure 2
Schematic diagram summarizing functional roles of BMPs and GDF9 in the human ovary. The potential physiological roles of intra-ovarian BMPs in regulating human ovarian functions, including steroidogenesis, activin production, cumulus–oophorus complex formation and expansion, cell–cell communication, ovulation and luteolysis are shown. BMP, bone morphogenetic protein; COC, cumulus–oophorus complex; Cx43, connexin 43; GC, granulosa cell; HAS2, hyaluronan synthase type 2; PTX3, pentraxin 3; StAR, steroidogenic acute regulatory protein.
Figure 3
Figure 3
Schematic diagram summarizing potential roles of GDF8 in a human growing follicle. In this follicular microenvironment, the locally produced GDF8 may promote aromatase/estradiol and FSHR expression, suppress StAR/progesterone and LHR expression and down-regulate PTX3 expression. In addition, GDF8 induces the expression of CTGF, which contributes to the suppression of GC proliferation and the increase in LOX activity. 3βHSD, 3β-hydroxysteroid dehydrogenase; CTGF, connective tissue growth factor; ECM, extracellular matrix; LOX, lysyl oxidase; P450scc, P450 side-chain cleavage enzyme; PTX3, pentraxin 3; FSHR, FSH receptor; LHR, LH receptor.

Similar articles

Cited by

References

    1. Aaltonen J, Laitinen MP, Vuojolainen K, Jaatinen R, Horelli-Kuitunen N, Seppa L, Louhio H, Tuuri T, Sjoberg J, Butzow R et al. Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis. J Clin Endocrinol Metab 1999;84:2744–2750. - PubMed
    1. Abir R, Ben-Haroush A, Melamed N, Felz C, Krissi H, Fisch B. Expression of bone morphogenetic proteins 4 and 7 and their receptors IA, IB, and II in human ovaries from fetuses and adults. Fertil Steril 2008;89:1430–1440. - PubMed
    1. Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update 2006;12:731–746. - PubMed
    1. Ackert CL, Gittens JE, O'Brien MJ, Eppig JJ, Kidder GM. Intercellular communication via connexin43 gap junctions is required for ovarian folliculogenesis in the mouse. Dev Biol 2001;233:258–270. - PubMed
    1. Al-Azemi M, Kyrou D, Kolibianakis EM, Humaidan P, Van Vaerenbergh I, Devroey P, Fatemi HM. Elevated progesterone during ovarian stimulation for IVF. Reprod Biomed Online 2012;24:381–388. - PubMed

Substances

Grants and funding